Pages that link to "Q72865468"
Jump to navigation
Jump to search
The following pages link to Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment (Q72865468):
Displaying 50 items.
- Plasminogen-activator-producing Tumour (Q24683213) (← links)
- Occurrence of disseminated intravascular coagulation (DIC) in obstructive jaundice and its relation to biliary tract infection (Q33449259) (← links)
- Coagulation Studies in Haemolytic Uraemic Syndrome (Q33468650) (← links)
- Elimination of fibrinogen from synovial joints (Q33568385) (← links)
- The effect of dipyridamole on platelet function: correlation with blood levels in man. (Q34515587) (← links)
- Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects (Q34517370) (← links)
- Tissue plasminogen activator promotes platelet disaggregation in plasma (Q34576233) (← links)
- Hypothermia and coagulation defects in the newborn (Q35150031) (← links)
- Measurement during fibrinolytic therapy (Q35664170) (← links)
- Blood clotting abnormalitis in relation to pre-eclampsia: a review (Q35934578) (← links)
- Haemolytic-uraemic syndrome: survival after prolonged oliguria (Q36062299) (← links)
- Fibrin-fibrinogen degradation products in sera of normal infants and children (Q36062704) (← links)
- Identification of intrarenal fibrin deposition (Q36520019) (← links)
- Fibrinolytic components of human uterine arterial and venous blood (Q36525621) (← links)
- Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells (Q36554699) (← links)
- Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes (Q36619006) (← links)
- The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis (Q36633693) (← links)
- Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity (Q36637755) (← links)
- The effect of age on the fibrinolytic enzyme system (Q36659895) (← links)
- Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis (Q36660110) (← links)
- Coagulation fibrinolysis in sickle-cell disease (Q36660450) (← links)
- Blood clotting and fibrinolysis in areas with different water supplies (Q36675977) (← links)
- Coagulation studies in rheumatic heart disease (Q36771297) (← links)
- Haematological abnormalities in acute pancreatitis. A prospective study (Q36812070) (← links)
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency * (Q37038122) (← links)
- Dysfibrinogenemia associated with liver disease (Q37045458) (← links)
- Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis (Q37053493) (← links)
- Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit (Q37097524) (← links)
- Disseminated intravascular coagulation and head injury (Q39292359) (← links)
- Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness (Q39433519) (← links)
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states (Q39441547) (← links)
- Membranoproliferative glomerulonephritis with partial lipodystrophy: discordant occurrence in identical twins (Q39759250) (← links)
- Local and systemic factors in the pathogenesis of thrombosis (Q39991631) (← links)
- Spontaneous fibrinolysis in pulmonary embolism (Q40324458) (← links)
- Prognostic value of serum fibrinogen-related antigen levels after myocardial infarction (Q41116018) (← links)
- Latex-bound antifibrinogen test for plasma fibrinogen assay (Q41222184) (← links)
- Excess intravascular coagulation complicating low cardiac output (Q41238758) (← links)
- Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E (Q41243699) (← links)
- Fibrin-fibrinogen degradation products in cerebrospinal fluid (Q41243711) (← links)
- Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation (Q41248744) (← links)
- The effect of oxygen on the fibrinolytic enzyme system in vivo (Q41255291) (← links)
- The origin of fibrin breakdown products and the interpretation of their appearance in the circulation (Q41256664) (← links)
- The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle (Q41258694) (← links)
- A comparison of the TRCII and latex-particle tests for the titration of FR-antigen (Q41258955) (← links)
- The fibrinolytic enzyme system in hypertension (Q41261144) (← links)
- The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays (Q41265741) (← links)
- The pharmacological properties of fibrinogen degradation products (Q41334506) (← links)
- Acute promyelocytic leukemia with hypofibrinogenemia (Q41654876) (← links)
- Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma (Q41891147) (← links)
- Coagulation and fibrinolysis after injury (Q42407525) (← links)